Drug updated on 3/27/2024
Dosage Form | Injection (intravenous; 74 MBq (2 mCi)/mL) |
Drug Class | Multiple |
Ongoing and Completed Studies | ClinicalTrials.gov |
Indication
- Indicated for striatal dopamine transporter visualization using single photon emission computed tomography (SPECT) brain imaging to assist in the evaluation of adult patients with suspected Parkinsonian Syndromes (PS). It helps differentiate essential tremor from tremor due to PS (idiopathic Parkinson's disease, multiple system atrophy and progressive supranuclear palsy).
- As an adjunct to other diagnostic evaluations.
Product Monograph / Prescribing Information
Document Title | Year | Source |
---|---|---|
DaTscan (ioflupane I-123) Prescribing Information. | 2022 | GE Healthcare, Arlington Heights, IL |
Systematic Reviews / Meta-Analyses
Clinical Practice Guidelines
Document Title | Year | Source |
---|---|---|
The Diagnostic Pathway of Imaging in Clinical Practice for Parkinsonisms. | 2022 | International Parkinson and Movement Disorder Society |
CANM guidelines for imaging of the dopamine transport system in evaluation of movement disorders. | 2020 | The Canadian Journal of Nuclear Medicine |
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. | 2020 | European Journal of Nuclear Medicine and Molecular Imaging |
Canadian guideline for Parkinson disease. | 2019 | Canadian Medical Association Journal |
Canadian guideline for Parkinson disease – Executive summary. | 2019 | Canadian Medical Association Journal |